Adoption, feasibility and safety of a family medicine-led remote monitoring program for patients with COVID-19: a descriptive study.
Adult
Ambulatory Care
/ trends
COVID-19
/ epidemiology
COVID-19 Testing
/ methods
Canada
/ epidemiology
Comprehensive Health Care
Disease Transmission, Infectious
/ prevention & control
Family Health
Family Practice
/ methods
Feasibility Studies
Female
Humans
Male
Patient Care Team
/ organization & administration
Program Evaluation
SARS-CoV-2
/ isolation & purification
Social Support
Telemedicine
/ methods
Journal
CMAJ open
ISSN: 2291-0026
Titre abrégé: CMAJ Open
Pays: Canada
ID NLM: 101620603
Informations de publication
Date de publication:
Historique:
entrez:
2
4
2021
pubmed:
3
4
2021
medline:
13
4
2021
Statut:
epublish
Résumé
Virtual care for patients with coronavirus disease 2019 (COVID-19) allows providers to monitor COVID-19-positive patients with variable trajectories while reducing the risk of transmission to others and ensuring health care capacity in acute care facilities. The objective of this descriptive analysis was to assess the initial adoption, feasibility and safety of a family medicine-led remote monitoring program, COVIDCare@Home, to manage the care of patients with COVID-19 in the community. COVIDCare@Home is a multifaceted, interprofessional team-based remote monitoring program developed at an ambulatory academic centre, the Women's College Hospital in Toronto. A descriptive analysis of the first cohort of patients admitted from Apr. 8 to May 11, 2020, was conducted. Lessons from the implementation of the program are described, focusing on measure of adoption (number of visits per patient total, with a physician or with a nurse; length of follow-up), feasibility (received an oximeter or thermometer; consultation with general internal medicine, social work or mental health, pharmacy or acute ambulatory care unit) and safety (hospitalizations, mortality and emergency department visits). The COVIDCare@Home program cared for a first cohort of 97 patients (median age 41 yr, 67% female) with 415 recorded virtual visits. Patients had a median time from positive testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to first appointment of 3 (interquartile range [IQR] 2-4) days, with a median virtual follow-up time of 8 (IQR 5-10) days. A total of 4 (4%) had an emergency department visit, with no patients requiring hospitalization and no deaths; 16 (16%) of patients required support with mental and social health needs. A family medicine-led, team-based remote monitoring program can safely manage the care of outpatients diagnosed with COVID-19. Virtual care approaches, particularly those that support patients with more complex health and social needs, may be an important part of ongoing health system efforts to manage subsequent waves of COVID-19 and other diseases.
Sections du résumé
BACKGROUND
Virtual care for patients with coronavirus disease 2019 (COVID-19) allows providers to monitor COVID-19-positive patients with variable trajectories while reducing the risk of transmission to others and ensuring health care capacity in acute care facilities. The objective of this descriptive analysis was to assess the initial adoption, feasibility and safety of a family medicine-led remote monitoring program, COVIDCare@Home, to manage the care of patients with COVID-19 in the community.
METHODS
COVIDCare@Home is a multifaceted, interprofessional team-based remote monitoring program developed at an ambulatory academic centre, the Women's College Hospital in Toronto. A descriptive analysis of the first cohort of patients admitted from Apr. 8 to May 11, 2020, was conducted. Lessons from the implementation of the program are described, focusing on measure of adoption (number of visits per patient total, with a physician or with a nurse; length of follow-up), feasibility (received an oximeter or thermometer; consultation with general internal medicine, social work or mental health, pharmacy or acute ambulatory care unit) and safety (hospitalizations, mortality and emergency department visits).
RESULTS
The COVIDCare@Home program cared for a first cohort of 97 patients (median age 41 yr, 67% female) with 415 recorded virtual visits. Patients had a median time from positive testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to first appointment of 3 (interquartile range [IQR] 2-4) days, with a median virtual follow-up time of 8 (IQR 5-10) days. A total of 4 (4%) had an emergency department visit, with no patients requiring hospitalization and no deaths; 16 (16%) of patients required support with mental and social health needs.
INTERPRETATION
A family medicine-led, team-based remote monitoring program can safely manage the care of outpatients diagnosed with COVID-19. Virtual care approaches, particularly those that support patients with more complex health and social needs, may be an important part of ongoing health system efforts to manage subsequent waves of COVID-19 and other diseases.
Identifiants
pubmed: 33795222
pii: 9/2/E324
doi: 10.9778/cmajo.20200174
pmc: PMC8034257
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E324-E330Informations de copyright
© 2021 Joule Inc. or its licensors.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Immigr Minor Health. 2016 Dec;18(6):1522-1540
pubmed: 26364053
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
N Engl J Med. 2020 May 7;382(19):1858-1859
pubmed: 32251568
J Am Geriatr Soc. 2020 Aug;68(8):1657-1660
pubmed: 32338767
Cleve Clin J Med. 2020 Jun 11;:
pubmed: 32409432
BMJ. 2020 Mar 25;368:m1182
pubmed: 32213507
J Vocat Behav. 2020 Jun;119:103439
pubmed: 32390658
J R Soc Med. 2020 Jun;113(6):208-210
pubmed: 32521196
J Infect. 2020 Nov;81(5):816-846
pubmed: 32445728
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
CMAJ Open. 2020 May 23;8(2):E407-E413
pubmed: 32447283
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
NPJ Prim Care Respir Med. 2020 Jun 18;30(1):30
pubmed: 32555160
J Med Internet Res. 2020 Jul 2;22(7):e19514
pubmed: 32568727
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
J Am Med Inform Assoc. 2020 Aug 1;27(8):1326-1330
pubmed: 32392280
J Racial Ethn Health Disparities. 2020 Jun;7(3):398-402
pubmed: 32306369
Can Fam Physician. 2021 Jan;67(1):e6-e8
pubmed: 33483405